Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-11-14
1997-11-11
Carlson, Karen C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530300, 530350, C07K 1400, A61K 3700
Patent
active
056864140
ABSTRACT:
The present invention provides methods of treating a subject suffering from adverse effects, complications or conditions, associated with or resulting from corneal transplantation, by topical administration of suitable ophthalmic preparations of bactericidal/permeability-increasing (BPI) protein products.
REFERENCES:
patent: 5348942 (1994-09-01), Little et al.
Lin et al. 1996. Antimicrobial Agents & Chemo Therapy 40: 65-69.
Saunders et al 1995 Int'l J. Antimicrobial Agents 5: 259-263.
Nikolic et al 1986 Invastigative Opthalmology and Visual Science 27: 449-456.
Boisioly et al 1981 Am J Opthalmology 107: 647-654.
Carlson Karen C.
Xoma Corporation
LandOfFree
Methods of treating conditions associated with corneal transplan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating conditions associated with corneal transplan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating conditions associated with corneal transplan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1229117